Upadoz 45mg ER Tablet (Upadacitinib Extended-Release) | 28 Tablets | MSN Laboratories | JAK Inhibitor for Inflammatory Conditions | Prescription Required

Product Description

Upadoz 45mg ER Tablet contains Upadacitinib, a Janus kinase (JAK) inhibitor that lowers inflammation by calming overactive immune signalling. This is the highest strength in the Upadoz range, prescribed by specialists, mainly for short induction treatment in inflammatory bowel conditions. Key Benefits Targeted JAK inhibitor that reduces inflammatory immune signalling Once-daily extended-release tablet Induction-strength 45mg tablet for patients whose doctor has prescribed this dose Used under gastroenterology or specialist supervision